Abstract: A heteroarylamine compound includes protein kinase inhibition activity, a pharmaceutically acceptable salt thereof and a pharmaceutical composition for preventing and treating a disease caused by abnormal cell growth, which contains the compound as an active ingredient.
Type:
Grant
Filed:
November 20, 2015
Date of Patent:
March 7, 2017
Assignee:
KOREA INSTITITUE OF SCIENCE AND TECHNOLOGY
Inventors:
Tae Bo Sim, Ho Jong Yoon, Ji Hye Yoon, Woo Young Hur, Eun Joo Roh, Yeon Ui Kwak